143 related articles for article (PubMed ID: 8047827)
1. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.
Havelund T; Laursen LS; Lauritsen K
Scand J Gastroenterol Suppl; 1994; 201():69-73. PubMed ID: 8047827
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.
Bate CM; Green JR; Axon AT; Murray FE; Tildesley G; Emmas CE; Taylor MD
Aliment Pharmacol Ther; 1997 Aug; 11(4):755-63. PubMed ID: 9305486
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
Langtry HD; Wilde MI
Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
[TBL] [Abstract][Full Text] [Related]
4. Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis.
Zeitoun P
Scand J Gastroenterol Suppl; 1989; 166():83-7; discussion 94. PubMed ID: 2690335
[TBL] [Abstract][Full Text] [Related]
5. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.
Carlsson R; Dent J; Watts R; Riley S; Sheikh R; Hatlebakk J; Haug K; de Groot G; van Oudvorst A; Dalväg A; Junghard O; Wiklund I
Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):119-24. PubMed ID: 9581986
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of gastro-oesophageal reflux disease with omeprazole.
Lundell L
Scand J Gastroenterol Suppl; 1994; 201():74-8. PubMed ID: 8047829
[TBL] [Abstract][Full Text] [Related]
8. Esomeprazole: a review of its use in the management of acid-related disorders.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
[TBL] [Abstract][Full Text] [Related]
10. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
11. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
[TBL] [Abstract][Full Text] [Related]
12. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial.
Havelund T; Laursen LS; Skoubo-Kristensen E; Andersen BN; Pedersen SA; Jensen KB; Fenger C; Hanberg-Sørensen F; Lauritsen K
Br Med J (Clin Res Ed); 1988 Jan; 296(6615):89-92. PubMed ID: 3122967
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
Maton PN; Orlando R; Joelsson B
Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
[TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice.
Venables TL; Newland RD; Patel AC; Hole J; Copeman MB; Turbitt ML
Scand J Gastroenterol; 1997 Jul; 32(7):627-32. PubMed ID: 9246699
[TBL] [Abstract][Full Text] [Related]
19. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial.
Wu JC; Chan FK; Ching JY; Leung WK; Hui Y; Leong R; Chung SC; Sung JJ
Gut; 2004 Feb; 53(2):174-9. PubMed ID: 14724146
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
